Unicycive Therapeutics (UNCY) grants 47,941 RSUs to director Laumas
Rhea-AI Filing Summary
Laumas Sandeep reported acquisition or exercise transactions in this Form 4 filing.
Unicycive Therapeutics, Inc. director Sandeep Laumas received a grant of 47,941 restricted stock units on May 14, 2026, payable solely in common stock.
Of these, 19,976 RSUs vest upon grant and 3,995 vest monthly over seven months beginning June 1, 2026, subject to his continued service; post‑grant holdings total 47,941 RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Laumas Sandeep
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1 | 47,941 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 47,941 shares (Direct)
Footnotes (1)
- F1. Represents grant of restricted stock units payable solely in common stock of the Issuer. 19,976 shares vest upon grant and 3,995 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.
Key Figures
RSUs granted: 47,941 units
Immediate vesting RSUs: 19,976 units
Monthly vesting RSUs: 3,995 units
+2 more
5 metrics
RSUs granted
47,941 units
Grant to director Sandeep Laumas on May 14, 2026
Immediate vesting RSUs
19,976 units
Portion of RSU grant vesting upon grant
Monthly vesting RSUs
3,995 units
RSUs vesting monthly over seven months beginning June 1, 2026
Total RSUs after grant
47,941 units
Director’s RSU holdings following the reported grant
Grant price per RSU
$0.0000 per unit
Reported transaction price per restricted stock unit
Key Terms
Restricted Stock Units, vest, continued service
3 terms
Restricted Stock Units financial
"Represents grant of restricted stock units payable solely in common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vest financial
"19,976 shares vest upon grant and 3,995 vest monthly over 7 months"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
continued service financial
"over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did UNCY director Sandeep Laumas report in this Form 4/A?
Sandeep Laumas reported receiving a grant of 47,941 restricted stock units on May 14, 2026. The RSUs are payable solely in Unicycive common stock and follow a defined vesting schedule, subject to his continued service with the company.
How many restricted stock units were granted to UNCY director Sandeep Laumas and when do they vest?
Laumas was granted 47,941 restricted stock units on May 14, 2026. 19,976 RSUs vest upon grant, and 3,995 RSUs vest monthly over seven months beginning June 1, 2026, provided he continues serving Unicycive Therapeutics.
What type of security did UNCY grant to director Sandeep Laumas in this transaction?
The company granted Laumas restricted stock units payable solely in Unicycive common stock. Each unit represents the right to receive one share of common stock upon vesting, following the stated vesting schedule and service condition.
What are Sandeep Laumas’s reported holdings after the UNCY RSU grant?
Following the transaction, Laumas is reported to hold 47,941 restricted stock units directly. This figure reflects the entire RSU grant, including portions that vest immediately and those scheduled to vest monthly over seven months.
Are the UNCY restricted stock units granted to Sandeep Laumas subject to any conditions?
Yes. Vesting of the granted RSUs is subject to Laumas’s continued service with Unicycive Therapeutics. While some units vest upon grant, the remaining monthly vesting installments depend on his ongoing service through the vesting period.